What is the interpretation of a 94% sensitivity in a diagnostic test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

A sensitivity of 94% means that a diagnostic test correctly identifies 94% of people who truly have the condition being tested for, making it a valuable screening tool with a low false-negative rate. This interpretation is based on the concept that sensitivity denotes the proportion of subjects correctly given a positive assignment out of all subjects who are actually positive for the outcome, as explained in the study by 1. In other words, if 100 people actually have the disease, the test will correctly identify 94 of them as positive, while missing 6 cases (these are false negatives).

When considering the implications of a 94% sensitivity, it's essential to remember that sensitivity alone doesn't tell the complete story about a test's overall accuracy. A highly sensitive test with poor specificity might correctly catch most cases of disease but also incorrectly flag many healthy people as having the condition. The study by 2 highlights the importance of understanding the limitations of sensitivity and specificity in the context of diagnostic testing.

Key points to consider when interpreting a sensitivity of 94% include:

  • The test's ability to correctly identify those with the disease is high, but not perfect.
  • False negatives can still occur, and their implications should be considered in the context of the disease and patient population.
  • Sensitivity should be considered alongside specificity, as a balance between the two is crucial for a test's overall usefulness.
  • The prevalence of the condition in the population being tested and the individual patient's pre-test probability of disease should also be taken into account for comprehensive clinical decision-making, as discussed in 1.

In clinical practice, understanding the sensitivity of a diagnostic test, like a test with 94% sensitivity, is crucial for making informed decisions about patient care, including the potential need for further testing or alternative diagnostic approaches. However, the provided studies 3, 4, and 5 do not directly relate to the interpretation of sensitivity in diagnostic testing and thus do not influence the interpretation of a 94% sensitivity in this context.

Related Questions

Is it important that findings from a clinical study be generalizable to people with similar characteristics as the study participants, for Good Clinical Practice (GCP) certification?
What is the required timeframe for reporting a Serious Adverse Event (SAE) to the local Institutional Review Board (IRB) after becoming aware of the event?
In which situation is a Serious Adverse Event (SAE) not required to be reported to the National Institute on Drug Abuse (NIDA) or designee within 24 hours: A. The investigator considers the SAE unrelated to study intervention, B. The SAE is non-fatal and non-life-threatening, C. The SAE occurs in a behavioral study, D. The SAE occurs in a non-Investigational New Drug (IND) study, E. The SAE occurs in the post-treatment observation period, or F. None of the above?
What action should be taken in case of a protocol violation in a clinical trial?
Do researchers and research institutions have the primary responsibility for reporting and investigating allegations of research misconduct, specifically regarding Good Clinical Practice (GCP)?
What are the treatment options for atrial fibrillation (AF) with tachycardia?
When are irradiated red blood cells (RBCs) administered?
What is the difference between an Esophagram (Barium swallow) and a Modified Barium Swallow (MBS) study?
What factors influence the selection of study participants, including representativeness, acceptable cost, and adequate sample size?
What are the implications of Protein S deficiency?
What is the treatment for ST-Elevation Myocardial Infarction (STEMI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.